<DOC>
	<DOCNO>NCT02647827</DOCNO>
	<brief_summary>The hypothesis acupuncture equally effective metformin ( treatment combine lifestyle management ) improve whole body glucose homeostasis insulin resistant woman polycystic ovary syndrome ( PCOS ) , superior lifestyle management alone . The investigator hypothesize acupuncture metformin induce ovulation improve hyperandrogenism , well health relate quality life ( HRQoL ) symptom anxiety depression . Although equally effective ( acupuncture metformin ) , investigator hypothesize acupuncture associate less negative side-effects . The investigator also hypothesize treatment potential restore epigenetic molecular alteration target tissue ( endometrial- , adipose- , skeletal muscle tissue ) thus potential prevent development type 2 diabetes ( T2D ) .</brief_summary>
	<brief_title>Acupuncture Metformin Insulin Resistance Women With PCOS</brief_title>
	<detailed_description>Specific Aims The purpose study perform randomize controlled trial woman PCOS , compare effectiveness lifestyle management alone , combination acupuncture metformin treatment whole body glucose homeostasis , ultimate goal prevent development type 2 diabetes . Primary aim 1 . To determine clinical effectiveness 4 month 1 ) electroacupuncture + lifestyle management 2 ) metformin + lifestyle management , compare 3 ) lifestyle management , improvement insulin sensitivity measure HOMA-IR , insulin response glucose assess calculate area curve ( AUCinsulin ) oral glucose tolerance test ( OGTT ) , glucose regulation ( assessed analyze Hba1c level ) . Secondary aim 1 . To evaluate change secondary metabolic measure , include fast insulin , c-peptide , glucose , adipokines , calculation HOMA-B ( i.e . Islet β-cell function ) c-peptide index , assessment adipokines lipid profile , body size proportion body fat distribution . 2 . To determine change genome-wide gene expression DNA methylation profile relate insulin sensitivity fat , muscle endometrial tissue biopsy , biomarkers whole blood . 3 . To evaluate endocrine measure include menstrual pattern ovulation frequency , circulate hormone ( sex steroid , AMH , gonadotropin ) , excretion metabolite sex steroid urine . 4 . To determine change woman 's HRQoL , symptom anxiety depression , diet eat pattern , negative side-effects . 5 . To evaluate cost-effectiveness different treatment .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Hyperandrogenism</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Inclusion criterion woman PCOS : 1 . Age 18 40 year 2 . Body mass index ( BMI ) ≥25 ≤40 give 95 % woman PCOS BMI ≥25 insulin resistant ( 71,72 ) . 3 . PCOS diagnosis accord Rotterdam criterion 2003 ( 73 ) , least two follow three symptom : Clinical sign hyperandrogenism ( hirsutism acne ) ; oligo/amenorrhea ; and/or polycystic ovary ( PCOS ) . Hirsutism define selfreported FerrimanGallwey ( FG ) score ≥8 ( ≥5 Asian ) ( 74,75 ) . Acne define positive response question Do acne ? Oligomenorrhea define intermenstrual interval &gt; 35 day &lt; 8 menstrual bleeding past year . Amenorrhea &lt; 3 cycle per year . PCO define transvaginal ultrasound ≥12 follicle 29 mm and/or ovarian volume ≥10 ml one ovary . 4 . Willing sign consent form . Inclusion criterion control : Controls BMI &gt; 25 &lt; 40 , regular cycle 28 day ± 2 day , sign hyperandrogenism . They exclude menstrual irregularity , sign hyperandrogenism ( FG &gt; 4 ) , evidence PCO morphology ultrasound . Exclusion criterion woman 1 . Age &gt; 40 2 . Exclusion endocrine disorder nonclassic congenital adrenal hyperplasia ( 17hydroxyprogesterone &lt; 3nmol/L ) , androgen secrete tumor suspect Cushing 's syndrome . 3 . Having know renal disease ( creatinine clearance &lt; 60 mL/min ) , hepatic insufficiency , autoimmune disorder cancer . 4 . Any acute condition potential alter renal function cause tissue hypoxia . 5 . Type I diabetes . 6 . Pharmacological treatment ( cortizon , antidepressant , antidiabetic treatment insulin acarbose , hormonal contraceptive , hormonal ovulation induction drug judge discretion investigator ) within 12 week . Depo Provera similar within 6 month . 7 . Hypersensitivity metformin hydrochloride excipients . 8 . Blood pressure &gt; 160 / 100 mmHg 9 . Pregnancy breastfeed last 6 month 10 . Acupuncture last 2 month 11 . Daily smoke alcoholic intake 12 . Language barrier disabled person reduce ability understand information give . In total 50 control match baseline ( age , weight BMI ) woman PCOS . Controls undergo screen baseline visit , randomize treatment .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Acupuncture</keyword>
	<keyword>Metformin</keyword>
	<keyword>Glucose metabolism</keyword>
	<keyword>Hba1c</keyword>
</DOC>